Cyclosporine: all 397 studies that test it
Page 4 of 4. Open to participants first (32), then studies with results posted, then the rest; newest registration first within each.
- Topical Cyclosporine and Disease ProgressionCompletedNCT00567983Phase 4
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)CompletedNCT00549289Phase 3
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)CompletedNCT00548301Phase 3
- Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft FunctionStatus unknownNCT00541814Phase 4
- Interaction Between Rimonabant and Cyclosporine and TacrolimusCompletedNCT00525681Phase 4
- Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With SirolimusCompletedNCT00518375Phase 4
- Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving SirolimusCompletedNCT00507793Phase 4
- Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant RecipientsCompletedNCT00504543Phase 2
- Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)CompletedNCT00502073Phase 3
- Fibrosis in Renal AllograftsStatus unknownNCT00493194Phase 4
- Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic SyndromeCompletedNCT00488436Phase 4
- Maintenance Neoral Monotherapy Compared to Bitherapy in Renal TransplantationCompletedNCT00461825Phase 3
- Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant RecipientsCompletedNCT00428064Phase 3
- Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004CompletedNCT00426101Phase 3
- Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis PatientsCompletedNCT00408187Phase 3
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With RestasisCompletedNCT00407043Phase 4
- Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?CompletedNCT00405431Not applicable
- Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilCompletedNCT00389870Phase 3
- Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to PterygiaCompletedNCT00383396Phase 4
- The Effectiveness of Lower Cyclosporine Doses for PsoriasisWithdrawnNCT00377325Phase 2
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver TransplantationTerminatedNCT00375895Phase 3
- Efficacy of Topical Cyclosporin for Ocular RosaceaCompletedNCT00348335Phase 4
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT00337493Phase 4
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic AnemiaStatus unknownNCT00319878Phase 1/2
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet TransplantationCompletedNCT00286624Phase 1/2
- Aerosol Cyclosporine for Prevention of Lung RejectionCompletedNCT00268515Phase 2
- Metabolic Pattern of Cyclosporine A and Acute Renal FailureCompletedNCT00264355Phase 4
- Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney TransplantsCompletedNCT00257387Phase 1/2
- Verification Study of Ciclosporin for Atopic DermatitisCompletedNCT00232076Phase 3
- Long-term Study of Ciclosporin for Atopic DermatitisCompletedNCT00232063Phase 3
- Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant PatientsCompletedNCT00213590Phase 3
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00195468Phase 4
- Pilot Trial for Implementation of a MPA PK Monitoring StrategyCompletedNCT00187915Not applicable
- The Vienna Prograf and Endothelial Progenitor Cell StudyCompletedNCT00182559Phase 4
- Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant RecipientsCompletedNCT00171743Phase 4
- Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant RecipientsCompletedNCT00171509Phase 4
- Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation RecipientsCompletedNCT00171496Phase 4
- Study Evaluating Sirolimus in Kidney Transplant Recipients.CompletedNCT00167947Phase 3
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)CompletedNCT00167583Phase 3
- Sirolimus Blood Concentrations on Conversion From Oral Solution to TabletsStatus unknownNCT00166842Phase 4
- The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant PatientsStatus unknownNCT00166816Phase 4
- Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant NephropathyCompletedNCT00160966Phase 4
- Nordic Study in Cardiac and Lung Transplantation: Outcome in Relation to Cyclosporine Microemulsion C2 LevelsCompletedNCT00154193Phase 4
- Effects of Cyclosporine A on Pancreatic Insulin SecretionCompletedNCT00139035Phase 4
- Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following TransplantationCompletedNCT00139009Phase 4
- Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00119340Phase 1/2
- Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral RetinoblastomaActive, not recruitingNCT00110110Phase 2
- Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaStatus unknownNCT00093587Not applicable
- Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00089050Phase 2
- Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerWithdrawnNCT00085449Phase 1/2
- Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantCompletedNCT00078858Phase 1/2
- S0301 Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaCompletedNCT00066794Phase 2
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic AnemiaCompletedNCT00061360Phase 2
- Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00056095Phase 2
- To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis VulgarisCompletedNCT00050648Phase 1/2
- Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerCompletedNCT00031980Phase 2
- Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete RemissionCompletedNCT00031655Phase 2
- Increasing HAART-Induced Immune Restoration With CyclosporineCompletedNCT00031070Phase 2
- Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell MyocarditisCompletedNCT00027443Not applicable
- Steroid Withdrawal in Pediatric Kidney Transplant RecipientsTerminatedNCT00023244Phase 2
- Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00016419Phase 2
- Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited DisordersCompletedNCT00010361Not applicable
- Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00009776Phase 1
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast CancerStatus unknownNCT00009763Phase 1
- Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow TransplantCompletedNCT00008450Phase 1
- Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesCompletedNCT00008177Phase 1
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
- Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV MelanomaCompletedNCT00006233Phase 2
- Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyCompletedNCT00005988Phase 1
- Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal CancerCompletedNCT00005941Phase 2
- Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic AnemiaCompletedNCT00005935Phase 2
- Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell MyocarditisCompletedNCT00004482Phase 2
- Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00004208Phase 3
- Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal CancerCompletedNCT00003950Phase 2
- Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast CancerStatus unknownNCT00003920Phase 1
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem GliomaCompletedNCT00003625Phase 1
- Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple MyelomaCompletedNCT00003196Not applicable
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid LeukemiaCompletedNCT00003145Phase 2
- Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell TransplantationTerminatedNCT00003056Phase 3
- Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic LeukemiaTerminatedNCT00002961Phase 3
- Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantWithdrawnNCT00002790Phase 1/2
- Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002759Phase 1
- Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownNCT00002688Phase 2
- Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow TransplantationCompletedNCT00002456Phase 3
- Cyclosporine A to Treat Hypertrophic Cardiomyopathy (HCM)CompletedNCT00001965Phase 2
- Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
- Cyclosporin Implant to Treat UveitisCompletedNCT00001737Phase 1
- Treatment of Dry Eye Syndrome With Cyclosporin A Eye DropsCompletedNCT00001731Phase 2
- Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With CyclosporineCompletedNCT00001533Phase 1
- A Study To Test An Anti-Rejection Therapy After Kidney TransplantationTerminatedNCT00000936Phase 3
- A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV DiseaseCompletedNCT00000880Phase 2